This week, Shawn Wilkie and Dr. Ivan Zak welcome Alex Voda from The Cat Health Company to discuss how the startup became the first clinical-stage company focused on feline longevity. Alex explains why cats are better models than other species for pharmaceutical R&D and how repurposing existing drugs could accelerate new treatments. He shares insights into why longevity companies still move slowly, highlights common and unique feline aging mechanisms, and reflects on what these innovations could mean for veterinarians, pet owners, and the broader future of veterinary practice. Learn more about The Cat Health Company. Alex recommends Youtube - Alex Zhavoronkov at ARDD2024: Methylation Clocks and AI Life Models as Sources of Therapeutic Target.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Trump $82 Million Bond Spree, Brazil Tariffs 'Too High,' More
16 Nov 2025
Bloomberg News Now
Ex-Fed Gov Resigned After Rules Violations, Trump Buys $82 Mil of Bonds, More
16 Nov 2025
Bloomberg News Now
THIS TRUMP INTERVIEW WAS INSANE!
16 Nov 2025
HasanAbi
Epstein Emails and Trump's Alleged Involvement
15 Nov 2025
Conspiracy Theories Exploring The Unseen
New Epstein Emails Directly Implicate Trump - H3 Show #211
15 Nov 2025
H3 Podcast
Trump Humiliates Himself on FOX as They Call Him Out
15 Nov 2025
IHIP News